封面
市場調查報告書
商品編碼
2058307

植入式心臟節律器市場:按產品類型、應用、最終用戶和地區分類。

Implantable Cardiac Pacemaker Market, By Product Type, By Application, By End-User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年植入式心臟節律器市場規模估計為81億美元,預計2033年將達到140億美元。預計2026年至2033年,該市場將以7.1%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 81億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.10% 2033年市場規模預測: 140億美元

植入式心臟節律器是一種小型醫療設備,植入胸部或腹部,用於治療心律不整、心臟傳導阻滯和心房顫動。植入式心律調節器已從電池供電的電晶體穿戴式心律調節器發展到完全植入心臟腔內的無導線心律調節器。它們用於治療導致心律不整的心臟異常電訊號。植入式心律調節器利用低能量電訊號來加快緩慢的心率,控制異常快速的心率,並預防QT間期延長症候群-一種導致心臟異常電活動的疾病。這種綜合症是一種危險的疾病,會導致突發性、無法控制的心律不整。

市場動態

市場新進業者正致力於研發新型心臟心律調節器,這些心律調節器能夠控制異常心率,並監測和記錄患者的心臟電活動、體溫和呼吸頻率。植入式心臟節律器領域的技術進步,以及心血管疾病盛行率的不斷上升,預計將在預測期內推動植入式心臟節律器市場的成長。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球植入式心臟心律調節器市場的主要參與者進行了分析:公司概況、財務業績、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球植入式心臟節律器市場報告》旨在為業界的各種相關人員提供參考,包括投資者、供應商、植入式心臟心律調節器製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用植入式心臟心律調節器市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
    • 監管趨勢
    • 市場趨勢
    • 流行病學
    • 併購
    • 新產品上市及核准
    • PEST分析
    • 波特的分析

第4章 全球植入式心臟節律器市場:依產品類型分類,2021-2033年

  • 單腔心律調節器
  • 雙腔心律調節器
  • 雙心室節律器

第5章 全球植入式心臟節律器市場:依應用領域分類,2021-2033年

  • 心臟傳導阻滯
  • 心律不整
  • 心房顫動
  • 長QT間期症候群
  • 心搏過緩
  • 心搏過速
  • 其他

第6章 全球植入式心臟節律器市場:依最終用戶分類,2021-2033年

  • 醫院
  • 急診中心
  • 其他

第7章 全球植入式心臟節律器市場:按地區分類,2021-2033年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 非洲
  • 中東

第8章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Medtronic plc
    • BIOTRONIK, Inc.
    • Boston Scientific Corporation
    • St. Jude Medical
    • Vitatron Holding BV
    • Shree Pacetronix Ltd.
    • MEDICO SpA
    • Lepu Medical Technology Co Ltd.
    • LivaNova PLC
    • Qinming Medical

第9章

  • 參考
  • 分析師意見
  • 調查方法
簡介目錄
Product Code: CMI1663

Implantable Cardiac Pacemaker Market is estimated to be valued at USD 8.1 Bn in 2026 and is expected to reach USD 14.0 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 8.1 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.10% 2033 Value Projection: USD 14.0 Bn

Implantable cardiac pacemaker is a small device implanted in the chest or abdomen for the treatment of abnormal heart rhythms, arrhythmia, heart block, and atrial fibrillation. Implantable cardiac pacemaker is evolved from battery-powered transistorized wearable pacemakers to current leadless pacemaker, an entire pacemaker which is placed within cardiac chambers. Cardiac pacemakers are used to treat abnormal electrical signaling in the heart, which causes arrhythmias. Implantable cardiac pacemaker use low-energy electrical signals to speed up the slow heartbeat, help to control an abnormal and fast heart rhythm, and prevents long QT syndrome, a disorder of the heart's electrical activity, which causes sudden, uncontrollable, and dangerous arrhythmias.

Market Dynamics

Market players are engaged in developing novel pacemakers with ability to control the abnormal heart rhythm, monitor and record patient's heart's electrical activity, blood temperature, and breathing rate. Technological advances in the field of implantable cardiac pacemakers along with increasing prevalence of cardiovascular disease is projected to drive the growth of implantable cardiac pacemaker market over the forecast period.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global implantable cardiac pacemaker market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC and Qinming Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global implantable cardiac pacemaker market report caters to various stakeholders in this industry including investors, suppliers, implantable cardiac pacemakers manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the implantable cardiac pacemaker market.

Market Segmentation

  • By Product Type (Revenue, USD Bn, 2021-2033)
    • Dual Chamber Pacemaker
    • Single Chamber Pacemaker
    • Biventricular Pacemaker
  • By Application (Revenue, USD Bn, 2021-2033)
    • Heart Block
    • Arrhythmia
    • Atrial fibrillation
    • Long QT Syndrome
    • Bradycardia
    • Tachycardia
    • Others
  • By End-User (Revenue, USD Bn, 2021-2033)
    • Hospitals
    • Emergency Care Centers
    • Others
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Competitive Landscape
    • Medtronic plc
    • BIOTRONIK, Inc.
    • Boston Scientific Corporation
    • Jude Medical
    • Vitatron Holding B.V.
    • Shree Pacetronix Ltd.
    • MEDICO S.p.A.
    • Lepu Medical Technology Co Ltd.
    • LivaNova PLC
    • Qinming Medical.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet by Product Type
    • Market Snippet by Application
    • Market Snippet by End-User
    • Market Snippet by Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Regulatory Scenario
    • Market Trends
    • Epidemiology
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • PEST Analysis
    • Porter's Analysis

4. Global Implantable Cardiac Pacemaker Market, By Product Type, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-O-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Single Chamber Pacemaker
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Dual Chamber Pacemaker
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Biventricular Pacemaker
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)

5. Global Implantable Cardiac Pacemaker Market, By Application, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-O-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Heart Block
    • Introduction
    • Y-O-Y Growth Analysis, 2021 - 2033
  • Arrhythmia
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Atrial fibrillation
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Long QT Syndrome
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Bradycardia
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Tachycardia
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)

6. Global Implantable Cardiac Pacemaker Market, By End-User, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-O-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Emergency Care Centers
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (USD Bn)

7. Global Implantable Cardiac Pacemaker Market, By Regions, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-O-Y Growth Analysis, For Regions, 2022 - 2033
  • North America
    • Market Size and Forecast, By Product Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By End-User, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By End-User, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By End-User, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By End-User, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By End-User, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Northern Africa
      • Central Africa
      • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By End-User, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Medtronic plc
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • BIOTRONIK, Inc.
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Boston Scientific Corporation
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • St. Jude Medical
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Vitatron Holding B.V.
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Shree Pacetronix Ltd.
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • MEDICO S.p.A.
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Lepu Medical Technology Co Ltd.
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • LivaNova PLC
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Qinming Medical
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
      • Analyst Views

9. Section

  • References
  • Analyst Views
  • Research Methodology
  • About Us and Sales Contact